What the New Medicare Drug Price Negotiation Timeline Means for Beneficiaries

The Centers for Medicare & Medicaid Services (CMS) has released clearer details on the next phase of Medicare’s drug price negotiation program. By early February next year, the agency plans to publish the list of 15 drugs selected for the third round of negotiations.